Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00GNW
|
||||
Former ID |
DNC007131
|
||||
Drug Name |
2,6-diphenyl-8-(1-ethylpropyl)-1-deazapurine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528673] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H23N3
|
||||
Canonical SMILES |
CCC(CC)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4
|
||||
InChI |
1S/C23H23N3/c1-3-16(4-2)22-25-21-19(17-11-7-5-8-12-17)15-20(24-23(21)26-22)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3,(H,24,25,26)
|
||||
InChIKey |
GPQRSDCKVYJMOH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Inhibitor | [528673] | |
Adenosine A2a receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [528673] | ||
Adenosine A3 receptor | Target Info | Inhibitor | [528673] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Parkinson's disease | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.